Qianming Bai

1.7k total citations
82 papers, 1.2k citations indexed

About

Qianming Bai is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Qianming Bai has authored 82 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 22 papers in Cancer Research. Recurrent topics in Qianming Bai's work include Cholesterol and Lipid Metabolism (12 papers), HER2/EGFR in Cancer Research (10 papers) and Lung Cancer Treatments and Mutations (10 papers). Qianming Bai is often cited by papers focused on Cholesterol and Lipid Metabolism (12 papers), HER2/EGFR in Cancer Research (10 papers) and Lung Cancer Treatments and Mutations (10 papers). Qianming Bai collaborates with scholars based in China, United States and Germany. Qianming Bai's co-authors include Leyuan Xu, Xiaoyan Zhou, William M. Pandak, Shunlin Ren, Hu Yang, Xin Zhang, Genta Kakiyama, Lianhua Yin, Xiaobo Li and Xiaoli Zhu and has published in prestigious journals such as Nature Communications, Cancer Research and Scientific Reports.

In The Last Decade

Qianming Bai

73 papers receiving 1.2k citations

Peers

Qianming Bai
Yunn-Yi Chen United States
Xiaoming Xing China
Zhixing Guo China
Derek J. Erstad United States
Antje Habel Germany
Zhenfang Du China
Jeffrey A. Borgia United States
Dongwei Zhang United States
Tao Sun China
Shingo Sakashita Japan
Yunn-Yi Chen United States
Qianming Bai
Citations per year, relative to Qianming Bai Qianming Bai (= 1×) peers Yunn-Yi Chen

Countries citing papers authored by Qianming Bai

Since Specialization
Citations

This map shows the geographic impact of Qianming Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qianming Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qianming Bai more than expected).

Fields of papers citing papers by Qianming Bai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qianming Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qianming Bai. The network helps show where Qianming Bai may publish in the future.

Co-authorship network of co-authors of Qianming Bai

This figure shows the co-authorship network connecting the top 25 collaborators of Qianming Bai. A scholar is included among the top collaborators of Qianming Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qianming Bai. Qianming Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yin, Xiaona, Dan Huang, I Weng Lao, et al.. (2025). Extrauterine RAD51B-Rearranged Soft Tissue Tumors. The American Journal of Surgical Pathology. 50(2). 204–217.
2.
Zhang, Xin, Qianming Bai, Yulin Wang, et al.. (2025). FGFR2 fusion/rearrangement analysis in intrahepatic cholangiocarcinoma using DNA/RNA-based NGS and FISH. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 487(5). 1103–1115. 1 indexed citations
3.
Ren, Min, Midie Xu, Ran Wei, et al.. (2025). Mutational landscape and DNA methylation-based classification of squamous cell carcinoma and urothelial carcinoma. Clinical Epigenetics. 17(1). 95–95.
4.
Bai, Qianming, Ming Li, Shuling Zhou, et al.. (2024). Response to anti-HER2 neoadjuvant chemotherapy in HER2-positive invasive breast cancers with different HER2 FISH patterns. Journal of Clinical Pathology. 78(8). 540–547. 3 indexed citations
5.
6.
Yao, Qianlan, Min Ren, Tian Xue, et al.. (2024). Clinicopathological Features of CCDC6-RET and NCOA4-RET Fusions in Thyroid Cancer: A Single-Center Retrospective Cohort Study in a Chinese Population. Thyroid. 34(10). 1260–1270. 1 indexed citations
7.
Lao, I Weng, et al.. (2023). NR1D1‐rearranged soft tissue tumour: A clinicopathological and molecular analysis of four additional cases. Histopathology. 84(4). 661–670. 2 indexed citations
8.
Yu, Baohua, Rui Bi, Xiaoli Xu, et al.. (2023). Conversion of ER and HER2 Status After Neoadjuvant Therapy in Chinese Breast Cancer Patients. Clinical Breast Cancer. 23(4). 436–446. 8 indexed citations
9.
Kong, Hui, Qianming Bai, Anqi Li, Xiaoyan Zhou, & Wentao Yang. (2022). Characteristics of HER2-negative breast cancers with FISH-equivocal status according to 2018 ASCO/CAP guideline. Diagnostic Pathology. 17(1). 5–5. 8 indexed citations
10.
11.
Ren, Min, Jing Zhang, Qianming Bai, et al.. (2021). BRAF, C-KIT, and NRAS mutations correlated with different clinicopathological features: an analysis of 691 melanoma patients from a single center. Annals of Translational Medicine. 10(2). 31–31. 8 indexed citations
12.
Wang, Zhe, Qiufeng Zhao, Qianming Bai, et al.. (2019). Machine Learning-Based Analysis of MR Multiparametric Radiomics for the Subtype Classification of Breast Cancer. Frontiers in Oncology. 9. 505–505. 62 indexed citations
13.
Bi, Rui, Qianming Bai, Xiaoli Zhu, et al.. (2019). ALK rearrangement: a high-frequency alteration in ovarian metastasis from lung adenocarcinoma. Diagnostic Pathology. 14(1). 96–96. 11 indexed citations
14.
Xu, Xiaoli, et al.. (2018). [Angiofibroma of soft tissue: a clinicopathologic analysis of 24 cases].. PubMed. 47(8). 616–621. 2 indexed citations
15.
Jia, Yijun, Weige Wang, Rui Bi, et al.. (2018). Integrative analysis of PD‐L1 DNA status, mRNA status and protein status, and their clinicopathological correlation, in diffuse large B‐cell lymphoma. Histopathology. 74(4). 618–628. 15 indexed citations
16.
Zhao, Qiufeng, Caixia Fu, Qianming Bai, et al.. (2018). Differentiation of triple-negative breast cancer from other subtypes through whole-tumor histogram analysis on multiparametric MR imaging. European Radiology. 29(5). 2535–2544. 66 indexed citations
17.
18.
Zhu, Xiaoli, Yanli Luo, Qianming Bai, et al.. (2016). Specific immunohistochemical detection of the BRAF V600E mutation in primary and metastatic papillary thyroid carcinoma. Experimental and Molecular Pathology. 100(1). 236–241. 25 indexed citations
19.
Xu, Leyuan, Qianming Bai, Xin Zhang, et al.. (2012). 5-Cholesten-3β,25-Diol 3-Sulfate Decreases Lipid Accumulation in Diet-Induced Nonalcoholic Fatty Liver Disease Mouse Model. Molecular Pharmacology. 83(3). 648–658. 29 indexed citations
20.
Ning, Yanxia, Qianming Bai, Hong Lü, et al.. (2008). Overexpression of mitochondrial cholesterol delivery protein, StAR, decreases intracellular lipids and inflammatory factors secretion in macrophages. Atherosclerosis. 204(1). 114–120. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yunn-Yi Chen Breakdown of academic impact, for papers by Xiaoming Xing Breakdown of academic impact, for papers by Zhixing Guo Breakdown of academic impact, for papers by Derek J. Erstad Breakdown of academic impact, for papers by Antje Habel Breakdown of academic impact, for papers by Zhenfang Du Breakdown of academic impact, for papers by Jeffrey A. Borgia Breakdown of academic impact, for papers by Dongwei Zhang Breakdown of academic impact, for papers by Tao Sun Breakdown of academic impact, for papers by Shingo Sakashita
Rankless by CCL
2026